MMP9 and cancer: We revealed that miR-491-5p also directly targeted RABIF and downregulated RABIF-mediated TNBC cancer stemness, drug resistance, cell invasion, and pulmonary metastasis via matrix metalloproteinase (MMP)-2 and MMP-9 signaling.